Table 2 Applications of paclitaxel liposome

Treatment line of paclitaxel liposome, n (%)

 First-line

33 (67.3%)

 Second-line

9 (18.4%)

 Third-line

1 (2.0%)

 Fourth-line

3 (6.1%)

 Fifth-line

3 (6.1%)

Dose of paclitaxel liposome (mg/m²), median (IQR)

135.0 (127.0, 150.0)

Total dose of paclitaxel liposome (mg), median (IQR)

240.0 (210.0, 270.0)

Cycles of paclitaxel liposome therapy, median (IQR)

5.0 (3.0, 6.0)

Cycles of paclitaxel liposome therapy, n (%)

 1

2 (4.1%)

 2

9 (18.4%)

 3

6 (12.2%)

 4

6 (12.2%)

 5

9 (18.4%)

 6

5 (10.2%)

 7

2 (4.1%)

 8

3 (6.1%)

 9

1 (2.0%)

 10

1 (2.0%)

 13

1 (2.0%)

 14

1 (2.0%)

 15

3 (6.1%)